Annual CAPEX
N/A
30 September 2023
Summary:
Outlook Therapeutics annual capital expenditures is not available.OTLK CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
N/A
30 June 2024
Summary:
Outlook Therapeutics quarterly capital expenditures is not available.OTLK Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
N/A
30 June 2024
Summary:
Outlook Therapeutics TTM capital expenditures is not available.OTLK TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OTLK CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
OTLK CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time |
Outlook Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | $437.30 K(-84.3%) | $0.00(-100.0%) | $437.20 K(-74.3%) |
| June 2019 | - | $150.70 K(+200.8%) | $1.70 M(-1.0%) |
| Mar 2019 | - | $50.10 K(-78.8%) | $1.72 M(-11.6%) |
| Dec 2018 | - | $236.40 K(-81.3%) | $1.94 M(-30.2%) |
| Sept 2018 | $2.78 M(+852.1%) | $1.26 M(+651.7%) | $2.78 M(+80.3%) |
| June 2018 | - | $168.00 K(-39.0%) | $1.54 M(+6.3%) |
| Mar 2018 | - | $275.20 K(-74.4%) | $1.45 M(+19.0%) |
| Dec 2017 | - | $1.08 M(+4379.6%) | $1.22 M(+317.3%) |
| Sept 2017 | $292.10 K | $24.00 K(-68.5%) | $292.10 K(-51.0%) |
| June 2017 | - | $76.20 K(+75.2%) | $596.50 K(-38.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | $43.50 K(-70.7%) | $972.80 K(+10.2%) |
| Dec 2016 | - | $148.40 K(-54.8%) | $882.40 K(-19.7%) |
| Sept 2016 | $1.10 M(-87.5%) | $328.40 K(-27.4%) | $1.10 M(-73.0%) |
| June 2016 | - | $452.50 K(-1064.8%) | $4.06 M(-42.8%) |
| Mar 2016 | - | -$46.90 K(-112.9%) | $7.10 M(-17.8%) |
| Dec 2015 | - | $364.20 K(-88.9%) | $8.64 M(-1.9%) |
| Sept 2015 | $8.80 M(+272.0%) | $3.29 M(-5.6%) | $8.80 M(+59.8%) |
| June 2015 | - | $3.49 M(+133.8%) | $5.51 M(+172.7%) |
| Mar 2015 | - | $1.49 M(+182.8%) | $2.02 M(+282.8%) |
| Dec 2014 | - | $527.90 K | $527.90 K |
| Sept 2014 | $2.37 M | - | - |
FAQ
- What is the all time high annual CAPEX for Outlook Therapeutics?
- What is the all time high quarterly CAPEX for Outlook Therapeutics?
- What is the all time high TTM CAPEX for Outlook Therapeutics?
What is the all time high annual CAPEX for Outlook Therapeutics?
Outlook Therapeutics all-time high annual capital expenditures is $8.80 M
What is the all time high quarterly CAPEX for Outlook Therapeutics?
Outlook Therapeutics all-time high quarterly capital expenditures is $3.49 M
What is the all time high TTM CAPEX for Outlook Therapeutics?
Outlook Therapeutics all-time high TTM capital expenditures is $8.80 M